TAK-981
TAK-981-1503
Phase 2 small_molecule terminated
Quick answer
TAK-981 for Relapsed and/or Refractory Multiple Myeloma (RRMM) is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Relapsed and/or Refractory Multiple Myeloma (RRMM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated